NCT06418932

Compression Therapy of the Lower Limbs in Patients With Decompensated Heart Failure

Compression Therapy of the Lower Limbs in Patients With Decompensated Heart Failure and Predominant Systemic Tissue Congestion
Fundación para la Investigación del Hospital Clínico de Valencia·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Heart Failure
Drug/Device/Intervention
UrgoK2 / UrgoK2 Lite
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
Location
Valencia, Spain
Timeline & enrollment
Phase
N/A
Start date
May 07, 2024
End date
Jul 01, 2026
Enrollment
106 participants
Primary outcome

Natriuresis,Weight

Summary

Randomized 1:1 multicenter double-blind clinical investigation evaluating the efficacy and
 safety of compression therapy of the lower limbs plus parenteral administration of diuretics
 vs. administration of parenteral diuretics alone (standard treatment) in patients with
 decompensated HF and predominantly systemic tissue congestion and absence of intravascular
 systemic congestion.
 
 Patients will be assigned to standard treatment (parenteral administration of furosemide)
 versus parenteral administration of furosemide plus lower limb compression therapy for up to
 72 hours. The dose of furosemide in all participants will be based on the clinical judgment
 of the responsible healthcare professional.

ICD-10 classifications
Heart failureHeart failure, unspecifiedCongestive heart failureHypertensive heart disease with (congestive) heart failureLeft ventricular failure
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06418932
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06418932 through Pure Global AI's free database. This phase not specified trial is sponsored by Fundación para la Investigación del Hospital Clínico de Valencia and is currently Recruiting. The study focuses on Heart Failure. Target enrollment is 106 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.